NDC 55154-4747-05 - Labetalol Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55154-4747
- Requested NDC
- 55154-4747-05
- Package NDCs from labels
- 55154-4747-5, 55154-4747-05
- Manufacturer
- Cardinal Health 107, LLC
- Effective date
- 2026-06-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Labetalol Hydrochloride - Cardinal Health 107, LLC | Cardinal Health 107, LLC | 2026-06-03 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55154-4747-5 | Labetalol Hydrochloride | 4 mL in 1 CARTRIDGE | INJECTION, SOLUTION | 4 | 12 | |
| 55154-4747-5 | Labetalol Hydrochloride | 5 in 1 BAG | INJECTION, SOLUTION | 5 | 12 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 55154-4747 | LABETALOL HYDROCHLORIDE INJECTION, SOLUTION [CARDINAL HEALTH 107, LLC] | 11 | Current NDC, Legacy NDC, 2 package rows | 20240929_1b96ddc9-d0c3-488a-a113-66491fd3d899.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| LABETALOL HYDROCHLORIDE | ACTIVE INGREDIENT | 1GEV3BAW9J | LABETALOL HYDROCHLORIDE INJECTION, SOLUTION [CARDINAL HEALTH] | 1 | |
| LABETALOL | ACTIVE MOIETY | R5H8897N95 | LABETALOL HYDROCHLORIDE INJECTION, SOLUTION [CARDINAL HEALTH] | 1 | |
| ANHYDROUS DEXTROSE | INACTIVE INGREDIENT | 5SL0G7R0OK | LABETALOL HYDROCHLORIDE INJECTION, SOLUTION [CARDINAL HEALTH] | 1 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | LABETALOL HYDROCHLORIDE INJECTION, SOLUTION [CARDINAL HEALTH] | 1 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | LABETALOL HYDROCHLORIDE INJECTION, SOLUTION [CARDINAL HEALTH] | 1 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | LABETALOL HYDROCHLORIDE INJECTION, SOLUTION [CARDINAL HEALTH] | 1 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | LABETALOL HYDROCHLORIDE INJECTION, SOLUTION [CARDINAL HEALTH] | 1 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | LABETALOL HYDROCHLORIDE INJECTION, SOLUTION [CARDINAL HEALTH] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GUNA-FLAM | ACONITUM NAPELLUS - APIS MELLIFERA - ATROPA BELLADONNA - BASIC CUPRIC CARBONATE - BRYONIA ALBA ROOT - CALCIUM SULFIDE - CITRIC ACID MONOHYDRATE - FERRIC PHOSPHATE - INTERLEUKIN-10 - MELATONIN - METENKEFALIN - PHYTOLACCA AMERICANA ROOT - RANCID BEEF - SODIUM PYRUVATE - SUS SCROFA CONJUNCTIVA - SUS SCROFA PINEAL GLAND - SUS SCROFA PITUITARY GLAND - TRANSFORMING GROWTH FACTOR BETA-1 - ANTI-INTERLEUKIN-1.ALPHA. IMMUNOGLOBULIN G RABBIT - | Guna spa | 7bda7eb0-8fd5-42d9-b336-39920bfc964d | 2026-06-10 | Warnings | 2968PHW8QP |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | BluePoint Laboratories Inc. | 63ede355-42ec-4c52-a941-51e5f6b35ed6 | 2026-06-08 | Warnings, Adverse reactions | 1GEV3BAW9J |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Bryant Ranch Prepack | 9c3bb751-c425-43ff-b530-2460b568b689 | 2026-06-05 | Warnings, Adverse reactions | 1GEV3BAW9J |
| LABETALOL HYDROCHLORIDE | LABETALOL HYDROCHLORIDE | A-S Medication Solutions | fffb7c59-ad92-4e74-850d-d94d42b7fdc9 | 2026-06-04 | Warnings, Adverse reactions | 1GEV3BAW9J |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Cardinal Health 107, LLC | 1b96ddc9-d0c3-488a-a113-66491fd3d899 | 2026-06-03 | Warnings, Adverse reactions | ANDA075239 55154-4747-5 55154-4747 55154474705 1234256 77254c29-bfa3-4f35-aaca-d9950c63545a 1b96ddc9-d0c3-488a-a113-66491fd3d899 1GEV3BAW9J |
| LABETALOL HYDROCHLORIDE | LABETALOL HYDROCHLORIDE | Bryant Ranch Prepack | 04f9dcdf-4023-48ee-9e7d-ca9366d9db72 | 2026-05-22 | Warnings, Adverse reactions | 1GEV3BAW9J |
| ACD A | CITRIC ACID MONOHYDRATE, DEXTROSE MONOHYDRATE, AND TRISODIUM CITRATE DIHYDRATE | Terumo BCT, Ltd | 8e255bc7-a120-460a-a32d-43931f8115de | 2026-05-21 | Warnings, Adverse reactions | 2968PHW8QP |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Cardinal Health 107, LLC | d3ca153c-25b2-4506-91bd-bf9d6a4c01fe | 2026-05-19 | Warnings, Adverse reactions | 1GEV3BAW9J |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Bryant Ranch Prepack | c0c1a162-cd30-4ac9-bc62-407493ed54a5 | 2026-05-11 | Warnings, Adverse reactions | 1GEV3BAW9J |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Proficient Rx LP | 54b75509-824b-4291-818d-71dc1b88915f | 2026-05-01 | Warnings, Adverse reactions | 1GEV3BAW9J |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Golden State Medical Supply, Inc. | d5ce687f-4a37-d3e6-e053-2995a90aa974 | 2026-04-16 | Warnings, Adverse reactions | 1GEV3BAW9J |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | A-S Medication Solutions | 371cb135-6a5f-433d-a87d-ab8521c4aa6d | 2026-04-16 | Warnings, Adverse reactions | 1GEV3BAW9J |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | A-S Medication Solutions | f9af85d3-a5a7-49d6-aff6-1ca2b2d75450 | 2026-04-16 | Warnings, Adverse reactions | 1GEV3BAW9J |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | NorthStar Rx LLC | 5bd81a8a-a480-4c8d-bd4f-3158412e6a73 | 2026-04-13 | Warnings, Adverse reactions | 1GEV3BAW9J |
| LABETALOL HYDROCHLORIDE | LABETALOL HYDROCHLORIDE | REMEDYREPACK INC. | ae5d7b3b-e444-48d3-9d85-9b07319f9374 | 2026-04-10 | Warnings, Adverse reactions | 1GEV3BAW9J |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID | Chartwell Governmental & Specialty RX, LLC | 58c24504-47de-487a-ab8d-18add155ea95 | 2026-04-07 | Adverse reactions | 2968PHW8QP |
| LABETALOL HYDROCHLORIDE | LABETALOL HYDROCHLORIDE | Advagen Pharma Ltd | 106a0959-5830-489f-ba60-afd4eb0fac36 | 2026-04-02 | Warnings, Adverse reactions | 1GEV3BAW9J |
| LABETALOL HYDROCHLORIDE | LABETALOL HYDROCHLORIDE | Advagen Pharma Ltd | 1c680447-b43a-4ff1-bc64-2c2174ca1c9a | 2026-04-02 | Warnings, Adverse reactions | 1GEV3BAW9J |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | A-S Medication Solutions | d4364caf-46c6-4144-9ba5-2c561e4f3a95 | 2026-03-26 | Warnings, Adverse reactions | 1GEV3BAW9J |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | A-S Medication Solutions | d207396a-068e-4229-88cc-a1a4df7aeff2 | 2026-03-07 | Warnings, Adverse reactions | 1GEV3BAW9J |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.